1 |
PLA-PEG |
LAP, PTX |
HER-2-negative, HER-2-positive |
[67] |
2 |
P(MeOx-b-BuOx-b-MeOx |
PTX, alkylated cisplatin |
Multidrug-resistant breast cancer |
[68] |
3 |
PEG-G3-PEITC |
PTX |
Breast cancer |
[69] |
4 |
Nonionic pluronic block copolymers |
DOX |
TNBC |
[70] |
5 |
PEG-PGlu-PPhA |
DOX, ALN |
Late-stage breast cancer bone metastasis |
[71] |
6 |
Zein with lactoferrin protein |
RAP, WOG |
Breast cancer |
[72] |
7 |
MPEG-PCL |
GA |
Breast cancer |
[73] |
8 |
Pluronic F127 block copolymer and Vitamin E-TPGS |
RES |
Breast cancer |
[74] |
9 |
Pluronic F127 block copolymer |
Zileuton |
TNBC |
[75] |
10 |
POEGMEMA-PtBuMA |
Estrogen |
Hormone-responsive breast cancer |
[76] |
11 |
PF-FA |
FS |
Breast cancer |
[77] |
12 |
INT |
DOX, PTX |
Breast cancer |
[78] |
13 |
POEG-VBC |
DOX, tRNA-mir-34a |
Metastatic breast cancer |
[79] |
14 |
Pluronic PF127-pluronic F68 with folate |
CH |
Breast cancer |
[80] |
15 |
Pluronic F127 with HA-DOCA-His-PF |
DOX |
Multidrug-resistant breast cancer |
[81] |
16 |
Cholic acid with poly (bis (carboxyphenoxy) phosphazene |
PTX |
Breast cancer |
[82] |
17 |
BD-PEI and BD-peptide-PEG |
DTX |
Metastatic breast cancer |
[83] |
18 |
PEG-poly(amino acid) block |
EPI |
ALNM of TNBC |
[84] |
19 |
PEOz-PLA |
PTX, HNK |
Multidrug-resistant and metastatic breast cancer |
[85] |
20 |
PELA-PBAE |
PTX |
Metastatic breast cancer |
[86] |
21 |
mPEG-CS-Hz-CH |
PTX |
Breast cancer |
[87] |
22 |
PLGA-BS-ATRAM |
DOX-TPP |
Breast cancer |
[89] |
23 |
mPEG-Dlabile-PCL-Fc |
DOX |
Breast cancer |
[90] |
24 |
mPEG-PCL |
MTX |
Breast cancer |
[60] |
25 |
mPEG-b-poly(εCL-co-αN3εCL |
MTX |
Breast cancer |
[91] |
26 |
HA-ss-BF |
DOX |
Breast cancer |
[92] |
27 |
PEG-PEI-PCL-S–S-PCL-PEG (PPPT) |
DOX |
Breast cancer |
[93] |
28 |
PEG, PPE |
DOX |
Multidrug-resistant breast cancer |
[64] |
29 |
PEG, polycaprolactone, RGD peptide |
DOX, ICG |
Breast cancer |
[94] |
30 |
poly(Tyrosine(alkynyl)-OCA), monomethoxy poly(ethylene glycol)-b-poly(Tyrosine(alkynyl)-OCA) |
Camptothecin |
Breast cancer |
[95] |
31 |
P5kSSLV |
DOX |
Multidrug-resistant breast cancer |
[96] |
32 |
DSPE-PEG2000 |
IR780 |
Breast cancer lymphatic metastasis |
[97] |
33 |
mPEG-PCL copolymer |
DTX, IR780 |
Breast cancer |
[98] |
34 |
Poly(N-isopropylacrymaide) and polylactic acid |
Shikonin |
Breast cancer |
[99] |
35 |
Zein-lactoferrin copolymer, Fe3O4 nanoparticles |
DAS |
TNBC |
[52] |
36 |
Folate-conjugated dextran/retinoic acid copolymer, oleic acid |
DOX |
Breast cancer |
[65] |
37 |
mPEG-b-PHEP copolymer, iron oxide nanocubes |
Emodin |
Breast cancer |
[66] |
38 |
CSO-SS-Hex, HA, Speg copolymer, Fe3O4 nanoparticles |
GA |
TNBC |
[100] |
39 |
SHR, PLGLAGK-Mal, coated with anti-CD28 antibody |
CH223191 |
Breast cancer |
[101] |
40 |
HPMA, OEGMA, GFLG peptide |
DOX, Nifuroxazide |
Metastatic breast cancer |
[102] |